EW Earnings
Latest Revenue1.7B
Latest Net Income241.4M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.42 | 1.7B | 241.4M | +13.6% | -26.3% |
| Q1 2026 | $0.66 | 1.6B | 380.7M | +16.7% | +8.2% |
| Q4 2025 | $0.16 | 1.6B | 91.2M | +13.3% | -75.4% |
| Q3 2025 | $0.50 | 1.6B | 290.3M | +14.7% | -90.3% |
| Q2 2025 | $0.57 | 1.5B | 331.5M | +11.9% | -6.6% |
| Q1 2025 | $0.61 | 1.4B | 363.6M | +6.2% | +5.2% |
| Q4 2024 | $0.65 | 1.4B | 384.3M | +9.4% | +6.6% |
| Q3 2024 | $5.14 | 1.4B | 3.1B | +8.9% | +715.9% |
| Q2 2024 | $0.61 | 1.4B | 365.0M | — | — |
| Q1 2024 | $0.58 | 1.3B | 351.0M | — | — |
| Q4 2023 | $0.61 | 1.3B | 369.7M | — | — |
| Q3 2023 | $0.63 | 1.2B | 383.7M | — | — |
Edwards Lifesciences (EW) — Earnings